Induction Therapy With PD-1 Antibody Combined With Platinum-based Doublet Chemotherapy for Locally-advanced Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Pemetrexed (Primary) ; Serplulimab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jun 2024 Results (n=82; data cutoff date: 6 Jan 2024) presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 25 Apr 2024 According to a Shanghai Henlius Biotech media release, data from this trial to be presented at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting is set to take place from May 31 to June 4 in Chicago, the United States.
- 15 Mar 2023 New trial record